64
Views
1
CrossRef citations to date
0
Altmetric
Letter to the Editor

Expression of FusC gene Among methicillin resistant Staph aureus clinical isolates resistant to fusidic acid, Cairo, Egypt

ORCID Icon, ORCID Icon, &
Pages 878-879 | Received 03 Aug 2019, Accepted 10 Aug 2019, Published online: 26 Aug 2019

References

  • Souli M, Karaiskos I, Galani L, et al. Nationwide surveillance of resistance rates of Staphylococcus aureus clinical isolates from Greek hospitals, 2012–2013. Infect Dis (London). 2016;48:287–292.
  • Castanheira M, Watters AA, Mendes RE, et al. Occurrence and molecular characterization of fusidic acid resistance mechanisms among Staphylococcus spp. from European countries (2008). J Antimicrob Chemother. 2010;65:1353–1358.
  • Clinical and Laboratory Standards Institute. M100-S27. Performance standards for antimicrobial susceptibility testing: 27th informational supplement. Wayne (PA): CLSI; 2017.
  • The European Committee on Antimicrobial Susceptibility Testing. Routine and extended internal quality control for MIC determination and disk diffusion as recommended by EUCAST [Internet]. Version 6.0, 2016. Available from: http://www.eucast.org.
  • Abd El‐Hamid MI, Bendary MM, Merwad AMA, et al. What is behind phylogenetic analysis of hospital‐, community‐ and livestock‐associated methicillin‐resistant Staphylococcus aureus? Transbound Emerg Dis. 2019;66:1506–1517.
  • Elazhari M, Abu-Quatouseh LF, Elhabchi D, et al. Characterization of fusidic acid-resistant Staphylococcus aureus isolates in the community of Casablanca (Morocco). Int J Med Microbiol. 2012;302:96–100.
  • Castanheira M, Watters AA, Bell JM, et al. Fusidic acid resistance rates and prevalence of resistance mechanisms among Staphylococcus spp. isolated in North America and Australia, 2007–2008. Antimicrob Agents Chemother. 2010;54:3614–3617.
  • Jung MY, Chung JY, Lee HY, et al. Antibiotic susceptibility of Staphylococcus aureus in atopic dermatitis: current prevalence of methicillin-resistant Staphylococcus aureus in Korea and treatment strategies. Ann Dermatol. 2015;27:398–403.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.